Stock Market & Financial News
Can BWXT's Manufacturing Investments Support Future Growth?
BWX Technologies expands manufacturing investments to strengthen production capacity across defense, commercial nuclear and advanced reactor markets.
BWXT GSK Discontinues Development of Camlipixant for Refractory Chronic Cough
GSK drops camlipixant's refractory chronic cough program after mixed phase III results, but the drug remains in a phase IIb study for irritable bowel syndrome.
GSK TXN Likely to Beat Q2 Earnings Estimates: How to Play the Stock?
Texas Instruments is poised for a Q2 earnings beat as analog and embedded chip demand rises, led by industrial, data center and automotive strength.
TXN Is SpaceX stock warming up to become the next meme stock?
SpaceX (SPCX) stock is tumbling further this morning after the firm's 13th Starship test flight was aborted right before liftoff as several engines failed to start properly. The development adds fuel to the bearish fire that has already assembled a $25 billion wall against billionaire Elon Musk's space infrastructure and artificial intelligence (AI) behemoth.
SPCX 
Morgan Stanley unlocks Bitcoin, Ethereum and Solana on E*TRADE
Morgan Stanley has completed the rollout of Bitcoin, Ethereum, and Solana trading on E*TRADE, charging eligible clients a 0.50% fee on each transaction.
Truecaller AB (publ) (TRUBF) Q2 2026 Earnings Call Transcript
Truecaller AB (publ) (TRUBF) Q2 2026 Earnings Call Transcript
TRUBF 
Alleima AB (publ) (SAMHF) Q2 2026 Earnings Call Transcript
Alleima AB (publ) (SAMHF) Q2 2026 Earnings Call Transcript
SAMHF 
Japanese Yen Short-term Outlook: USD/JPY Defends the Uptrend as the Range Tightens
USD/JPY USD/JPY closes week at an increasingly important technical juncture after spending the past three weeks consolidating within the July opening range. The pullback from the monthly highs found support at a key confluence zone, preserving the broader uptrend while allowing the pair to work off overextended conditions.
Meta's Agentic AI Leadership Strategy is Why I Can't Stop Buying Over and Over
I keep buying Meta Platforms (NASDAQ:META | META Price Prediction), and I am not planning to stop.
META 
Best Momentum Stocks to Buy for July 17th
JBTH, TSM and JPM made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 17, 2026.
JBHT 
Strategy CEO Says Bitcoin Must Crash to $10,000 Before Debt Risks Become a Concern
Strategy CEO Phong Le has sought to reassure investors that the company's balance sheet remains resilient despite Bitcoin's latest downturn.
Sweetgreen Stock Soars as Diners Take a Sigh of Relief Over Cyclospora Outbreak
Other food and restaurant stocks jumped, too, as investors likely hope that customers will resume their normal food-shopping habits.
SG 
Apple races past Nvidia to reclaim crown as world's most valuable company
Apple is reclaiming the top spot for the first time since April last year.
AAPL 
QuantumScape: Eagle Line Pilot Production Success Story
QuantumScape is rated a buy due to its strong execution on the Eagle Line pilot, signaling near-term commercialization potential. QS's Cobra process now achieves heat treatment speeds 25x faster, supporting scalable battery production and competitive energy densities up to 850 Wh/L. Customer billings are accelerating, with FY2026 annualized projections of $44 million, indicating robust B1 sample acceptance and readiness for automotive commercialization.
QS 
Novo Nordisk: The Oral Wegovy Promise
Novo Nordisk has made robust gains of 40% at the stock markets since April, supported by the success of oral Wegovy and attractive valuations. The Wegovy pill can see a nice revenue uptick in Q2 2026 going by recent data, and that can continue into the year as it gains approvals from international markets. Importantly, the pill has made gains even when competitor Eli Lilly's Foundayo has seen limited success, which can give Novo Nordisk a much-needed boost.
NVO 
Regions Financial Q2 Earnings Beat Estimates, NII, Expenses Up Y/Y
RF tops Q2 earnings estimates as NII and improving credit quality offset expense growth, but revenues fall short of expectations.
RF 
Packaging Corp Gears Up for Q2 Earnings: What to Expect?
PKG is set to post Q2 results on July 22, with revenues rising 10.7% as the Greif acquisition is expected to support earnings despite lower EPS estimates.
PKG 
AGNC Investment to Report Q2 Earnings: What's in Store for the Stock?
AGNC set to report Q2'26 earnings on July 20 as investors watch net interest income, asset yields and book value amid mortgage-rate volatility.
AGNC 
Liberty Energy Q2 Earnings on Deck: Here's How It Will Fare
Liberty Energy Inc. LBRT is set to report second-quarter 2026 earnings on July 22, after the closing bell. The Zacks Consensus Estimate for earnings is pegged at 7 cents per share, and the same for revenues is pinned at $1.09 billion.
LBRT 
Can Robust Premium Water Demand Sustain Primo Brands' Growth?
PRMB is expanding its premium water portfolio through brand investments, broader distribution and category momentum.
PRMB 
Travelers shares rise after Q2 earnings crush estimates on lower catastrophe losses
Travelers Companies Inc (NYSE:TRV) shares rose more than 8% on Friday after the insurer reported second-quarter earnings that significantly exceeded Wall Street expectations, helped by lower catastrophe losses, higher investment income and strong underwriting performance. The company posted adjusted core earnings of $10.04 per diluted share for the quarter ended June 30, comfortably ahead of the consensus estimate of about $5.39.
TRV 
Evolution AB (publ) (EVVTY) Q2 2026 Earnings Call Transcript
Evolution AB (publ) (EVVTY) Q2 2026 Earnings Call Transcript
EVVTY 
Yara International ASA (YARIY) Q2 2026 Earnings Call Transcript
Yara International ASA (YARIY) Q2 2026 Earnings Call Transcript
YARIY 
Aptos named by Coinbase's Quantum Advisory Council as top blockchain for post-quantum era
Coinbase's Quantum Advisory Council names Aptos and Algorand as the most prepared blockchains for post-quantum security in a new position paper. Aptos named by Coinbase's Quantum Advisory Council as top blockchain for post-quantum era.
The First Oral Cholesterol Pill Is Here. Which of These 5 Stocks Benefits Most?
The FDA's approval of Merck (NYSE:MRK | MRK Price Prediction) enlicitide decanoate, marketed as Lipfendra, marks the first once-daily oral PCSK9 inhibitor cleared for adults with high LDL cholesterol, including heterozygous familial hypercholesterolemia.
MRK 
Strength Seen in Erie Indemnity (ERIE): Can Its 7.5% Jump Turn into More Strength?
Erie Indemnity (ERIE) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
ERIE 
Netflix stock gets punished as company gets more secretive about viewer data
Netflix NFLX shares tumbled on Friday after the streaming giant delivered mixed second-quarter results and announced plans to provide less frequent disclosure of viewer engagement data. This has increased concerns among investors who were already worried about slowing growth and rising competition.
NFLX 
Fifth Third Bancorp Q2 Earnings Call Highlights
Fifth Third Bancorp NASDAQ: FITB reported second-quarter 2026 earnings that management said showed early benefits from its merger with Comerica, with executives pointing to stronger profitability, deposit growth in newer markets and progress toward planned cost savings.
TBBK 
Cohen & Steers Q2 Earnings Call Highlights
Cohen & Steers NYSE: CNS reported higher second-quarter 2026 adjusted earnings and assets under management, as executives pointed to improving demand for real estate, infrastructure, preferred securities and broader real assets strategies.
CNS 
F.N.B. Q2 Earnings Call Highlights
F.N.B. NYSE: FNB reported stronger second-quarter 2026 earnings, record revenue and continued balance sheet growth, while management lowered its full-year net interest income outlook, citing deposit competition and the impact of changes in short-term rates.
FNB 
